CD33 and Parkinson disease: In addition, several CD20- and CD33-expressing leukocytes increased the risk of Alzheimer’s disease; CD11-expressing leukocytes increased, and CD27- and CXCR1-expressing leukocytes decreased, Parkinson’s disease risk in MR sensitivity analyses.